51 participants
16-Hour Fasting Plus Serplulimab and CAPEOX as Neoadjuvant Therapy in pMMR/MSS Advanced Mid-to-Low Rectal Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-21
- Start Date:
- 2026-09-01
- Completion:
- 2028-12-31
Conditions
- pMMR/MSS
- Locally Advanced Rectal Carcinoma
- Fasting, Intermittent
Interventions
- BEHAVIORAL
- DRUG
No Results Yet